Integrating immunity: The immunculus and self-reactivity

Journal of Autoimmunity

Volumn 30, Issue 1-2, 2008, Pages 68-73

  Poletaev, Alexander B ^a,b,c   Stepanyuk, Vladimir L ^a,c   Eric Gershwin, M ^d  

^a Medical Research Center Immunculus   (Russian Federation)

^b P K ANOKHIN INSTITUTE OF NORMAL PHYSIOLOGY   (Russian Federation)

^c Institute of Systemic Nanomedicine and Biotechnology   (Russian Federation)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Immunculus; Immune system; Natural autoantibodies

Indexed keywords

ANTIGEN; AUTOANTIBODY; EPITOPE;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOLOGY; CELL POPULATION; CHEMICAL STRUCTURE; CLONE; DISEASE COURSE; EVOLUTION; EVOLUTIONARY HOMOLOGY; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; HOST; IMMUNE SYSTEM; IMMUNOREGULATION; LYMPHOCYTE; MEDICAL EDUCATION; MEDICAL RESEARCH; MICROORGANISM; NOMENCLATURE; NONHUMAN; ONTOGENY; PATHOGENESIS; PRIORITY JOURNAL; STEREOCHEMISTRY; THEORETICAL STUDY; THEORY; THYMUS;

EID: 38049031900     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.11.012     Document Type: Article

References (56)

1. Burnet F.M. Clonal selection theory of acquired immunity (1959), Vanderbilt University Press
2. Ludewig B., Krebs P., Metters H., Tatzel J., Türeci O., and Sahin U. Molecular characterization of virus-induced autoantibody responses. J Environ Monit 200 5 (2004) 637-646
3. Poletaev A.B. Clinical and laboratory immunology (2007), MIA, Moscow
4. Tishler M., and Shoenfeld Y. Vaccination may be associated with autoimmune diseases. Isr Med Assoc J 6 (2004) 430-432
5. Oldstone M.B.A. Molecular mimicry and immune-mediated diseases. FASEB J 12 (1998) 1255-1265
6. Tauber A. The biological notion of self and non-self. Stanford Encyclopedia of Philosophy (2006). http://plato.stanford.edu/entries/biology-self [accessed 08.06.07]
7. James L.C., and Tawfik D.S. The specificity of cross-reactivity: promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness. Protein Sci 12 (2003) 2183-2193
8. Dimitrov J.D., Ivanovska N.D., Lacroix-Desmazes S., Doltchinkova V.R., Kaveri S.V., and Vassilev T.L. Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G. J Biol Chem 281 (2006) 439-446
9. Charlambous B.M., and Feavers I.M. Mimotope vaccines. J Med Microbiol 50 (2001) 937-939
10. Zhou Z.-H., Zhang Y., Wahl L.M., Cisar J.O., and Notkins A.L. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 1 (2007) 51-61
11. Tauber A.I. The immunological self. A centenary perspective. Perspect Biol Med 35 (1991) 74-86
12. Matzinger P. The danger model: a renewed sense of self. Science 296 (2002) 301-305
13. Zaichik A.S., and Churilov L.P. The basics of patochemistry (2001), ELBI-SPB, St. Petersburg
14. Poletaev A.B., Abrosimova A.A., Sokolov M.A., Gekht A.B., Alferova V.V., Gusev E.I., et al. Dialectics and implications of natural neurotropic autoantibodies in neurological disease and rehabilitation. Clin Dev Immunol 11 2 (2004) 151-156
15. Poletaev A., and Osipenko L. General network of natural autoantibodies as immunological homunculus (immunculus). Autoimmun Rev 2 5 (2003) 264-271
16. Notkins A.L. New predictors of diseases. Sci Am 296 (2007) 72-79
17. Cohen I.R., and Young D.B. Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today 12 (1991) 105-110
18. Zanetti M. Ontogeny of the immune system and the invisible frontier to immune regulation. Int Rev Immunol 8 2-3 (1992) 209-218
19. Poletaev A.B., and Selifanova O.P. Transfer of elevated anti-S100 autoimmunity from mother to their offsprings in rats. Life Sci 54 (1994) 1377-1381
20. Poletaev A.B. Elevated serum immunoreactivity to S-100 protein in healthy mothers and their sick children: possible significance in inborn psychoneuropathology. Dev Brain Dysfunct 9 (1996) 17-21
21. Lemke H., and Lange H. Is there a maternally induced immunological imprinting phase a la Konrad Lorenz?. Scand J Immunol 50 (1999) 348-354
22. Borghesi C., and Nicoletti C. Autologous anti-idiotypic antibody response is regulated by the level of circulating complementary idiotype. Immunology 89 (1996) 172-177
23. Lima M.S., Gazzinelli G., Nascimento E., Parra J.C., Montesano M.A., and Colley D.G. Immune responses during human schistosomiasis mansoni. Evidence for antiidiotypic T lymphocyte responsiveness. J Clin Invest 78 4 (1986 October) 983-988
24. Bentley G.A., Boulot G., Riottot M.M., and Poljak R.J. Three-dimensional structure of an idiotope-anti-idiotope complex. Nature 348 (1990) 254-257
25. Anokhin P.K. The functional system theory (1979), Meditsina, Moscow
26. Sudakov K.V. General theory of the functional systems (1984), Meditsina, Moscow
27. Sherstnev V.V., Poletaev A.B., and Dolgov O.N. Natural oligopeptides and functions of the nervous system. Usp Fiziol Nauk 10 3 (1979) 66-86
28. Jerne N.K. Towards a network theory of the immune system. Ann Immunol (Inst Pasteur) 125 (1974) 373-389
29. Jerne N.K., and Cocteau J. Idiotypic networks and other preconceived ideas. Immunol Rev 79 1 (1984) 5-24
30. Shoenfeld Y. The idiotypic network in autoimmunity: antibodies that bind antibodies that bind antibodies. Nat Med 10 1 (2004) 17-18
31. Abraham M., Karni A., Dembinsky A., Miller A., Gandhi R., Anderson D., et al. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J Autoimmun 30 (2008) 21-28
32. Alvarado-Sanchez B., Hernández-Castro B., Portales-Pérez D., Baranda L., Layseca-Espinosa E., Abud-Mendoza C., et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 27 (2006) 110-118
33. Andreoli L., Pregnolato F., Burlingame R.W., Allegri F., Rizzini S., Fanelli V., et al. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity. J Autoimmun 30 (2008) 51-57
34. Awdeh Z.L., Yunis E.J., Audeh M.J., Fici D., Pugliese A., Larsen C.E., et al. A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease. J Autoimmun 27 (2006) 174-181
35. Bach J.F. Infections and autoimmune diseases. J Autoimmun 25 Suppl. (2005) 74-80
36. Binard A., Le Pottier L., Saraux A., Devauchelle-Pensec V., Pers J.-O., and Youinou P. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?. J Autoimmun 30 (2008) 63-67
37. Bugatti S., Codullo V., Caporali R., and Montecucco C. B cells in rheumatoid arthritis. Autoimmun Rev 6 (2007) 482-487
38. Cohen I.R. Biomarkers, self-antigens and the immunological homunculus. J Autoimmun 29 (2007) 246-249
39. Gleicher N., Barad D., and Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity?. Autoimmun Rev 7 (2007) 42-45
40. Jacobson E., Huber A., and Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 30 (2008) 58-62
41. Kallenberg C. Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 30 (2008) 99-103
42. Lan R.Y., Mackay I.R., and Eric Gershwin M. Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border. J Autoimmun 29 (2007) 272-280
43. Lang K.S., et al. The role of the innate immune response in autoimmune disease. J Autoimmun 29 (2007) 206-212
44. Mackay I.R., Leskovsek N., and Rose N.R. Cell damage and autoimmunity: a critical appraisal. J Autoimmun 30 (2008) 5-11
45. Lutz H.U. Homeostatic roles of naturally occurring antibodies: an overview. J Autoimmun 29 (2007) 287-294
46. Mantovani A., Garlanda C., Locati M., Rodriguez T.V., Feo S.G., Savino B., et al. Regulatory pathways in inflammation. Autoimmun Rev 7 (2007) 8-11
47. Nakanishi Y., Tsuneyama K., Fujimoto M., Salunga T.L., Nomoto K., An J.-L., et al. Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. J Autoimmun 30 (2008) 42-50
48. Papadimitraki E.D., Bertsias G.K., and Boumpas D.T. Toll like receptors and autoimmunity: a critical appraisal. J Autoimmun 29 (2007) 310-318
49. Praprotnik S., Sodin-Semrl S., Tomsic M., and Shoenfeld Y. The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun 30 (2008) 37-41
50. Recalcati S., Invernizzi P., Arosio P., and Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 30 (2008) 84-89
51. Sanchez-Pernaute O., Ospelt C., Neidhart M., and Gay S. Epigenetic clues to rheumatoid arthritis. J Autoimmun 30 (2008) 12-20
52. Selmi C. One year in autoimmunity. Autoimmun Rev 7 (2007) 85-93
53. Shoenfeld Y., and Gershwin M. Autoimmunity: from the mosaic to the kaleidoscope. J Autoimmun 30 (2008) 1-5
54. Vollmers H.P., and Brandlein S. Natural antibodies and cancer. J Autoimmun 29 (2007) 295-302
55. Williams Jr. R.C. Autoimmune disease etiology - a perplexing paradox or a turning leaf?. Autoimmun Rev 6 (2007) 204-208
56. Zandman-Goddard G., Peeva E., and Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 6 (2007) 366-372